Josep M. Llovet

About me

Featured publications

• Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment

  Authors:

  Llovet, Josep M; Willoughby, Catherine E; Singal, Amit G; Greten, Tim F; Heikenwaelder, Mathias;

  El-Serag, Hashem B; Finn, Richard S; Friedman, Scott L.

  Reference: Nature Reviews Gastroenterology & Hepatology 2023.

• International Liver cancer Association (ILCA) White Paper on Hepatocellular carcinoma Risk Stratification and Surveillance

  Authors:

  Singal, AG; Hoshida, Y; Rich, N; Sanduzzi-Zamparelli, M; Reig, M;

  (...)

  Vilgrain, V; Marrero, J; Llovet, JM; Villanueva, A; Parikh, ND.

  See complete list of authors

  Reference: Journal Of Hepatology 2023.

• Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma

  Authors:

  Haber PK; Castet F; Torres-Martin M; Andreu-Oller C; Puigvehí M;

  (...)

  Finn RS; Thung S; Villanueva A; Sia D; Llovet JM.

  See complete list of authors

  Reference: Gastroenterology 2023.

• Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification

  Authors:

  Montironi, C; Castet, F; Pinyol, R; Torres-Martin, M; Fontanals, LT;

  (...)

  Neely, J; Anderson, J; Mazzaferro, V; Roayaie, S; Sia, D.

  See complete list of authors

  Reference: Gut 2023.

• Immunotherapies for hepatocellular carcinoma

  Authors:

  Llovet, Josep M; Castet, Florian; Heikenwalder, Mathias; Maini, Mala K; Mazzaferro, Vincenzo;

  Pinato, David J; Pikarsky, Eli; Zhu, Andrew X; Finn, Richard S.

  Reference: Nature Reviews Clinical Oncology 2022.

• Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

  Authors:

  Pinyol, R; Torrecilla, S; Montironi, C; Piqué-Gili, M; Torres-Martin, M;

  (...)

  Roessler, S; Schirmacher, P; Minguez, B; Reeves, HL; Sanyal, A.

  See complete list of authors

  Reference: Journal Of Hepatology 2021.

• NASH limits anti-tumour surveillance in immunotherapy-treated HCC

  Authors:

  Pfister, D; Szydlowska, M; Müller, F; Heide, D; Stirm, K;

  (...)

  Zender, L; Marche, PN; Decaens, T; Jilkova, ZM; Pinato, DJ.

  See complete list of authors

  Reference: Nature 2021.

• Hepatocellular carcinoma

  Authors:

  Llovet, JM; Villanueva, A; Kelley, RK; Singal, AG; Pikarsky, E;

  Roayaie, S; Lencioni, R; Koike, K; Zucman-Rossi, J; Finn, RS.

  Reference: Nature Reviews Disease Primers 2021.

• Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

  Authors:

  Schulze, Kornelius; Imbeaud, Sandrine; Letouze, Eric; Alexandrov, Ludmil B; Calderaro, Julien;

  (...)

  Nault, Jean-Charles; Bioulac-Sage, Paulette; Stratton, Michael R; Llovet, Josep M; Zucman-Rossi, Jessica.

  See complete list of authors

  Reference: Nature Genetics 2015.

• Sorafenib in Advanced Hepatocellular Carcinoma

  Authors:

  Llovet, JM; Ricci, S; Mazzaferro, V; Hilgard, P; Gane, E;

  (...)

  Giannaris, T; Shan, M; Moscovici, M; Voliotis, D; Bruix, J.

  See complete list of authors

  Reference: New England Journal Of Medicine 2008.

Featured Projects

• Laboratori de Recerca Translacional en Oncologia Hepàtica

  Principal investigator: Josep M. Llovet Bayer

  Funder: Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)

  Code: AGAUR_SGR21

  Duration: 01/01/2022 - 31/12/2024

• Identification of biomarkers predicting response and resistance to immunotherapy in advanced hepatocellular carcinoma

  Principal investigator: Josep M. Llovet Bayer

  Funder: Asociación Española Contra el Cáncer

  Duration: 01/12/2021 - 30/11/2025

• Molecular characterization of obesity/diabetes/NASH-related hepatocellular carcinoma

  Principal investigator: Josep M. Llovet Bayer

  Funder: Agencia Estatal de Investigación

  Code: PID2019-105378RB-100

  Duration: 01/06/2020 - 31/05/2023

• HUNTER-Hepatocellular Carcinoma Expediter Network

  Principal investigator: Josep M. Llovet Bayer

  Funder: Asociación Española Contra el Cáncer (AECC)

  Code: AECC_AccAward17

  Duration: 01/12/2018 - 30/11/2025

  Web: https://www.cancerresearchuk.org/funding-for-researchers/accelerator-award/portfolio-funded-projects-outputs

• Mecanismos de resistencia adquirida a sorafenib en el carcinoma hepatocelular

  Principal investigator: Josep M. Llovet Bayer

  Funder: Ministerio de Economía y Competitividad

  Code: SAF2016-76390-R

  Duration: 31/12/2016 - 10/01/2020